164 results
Page 5 of 9
6-K
EX-99.2
67vlq j4uo4h3
27 Nov 19
Condensed Consolidated Interim Financial Statements
5:09pm
6-K
EX-99.1
jh4 snrtz448l6oqye
26 Nov 19
RepliCel Provides 2019 Year-End Update
12:41pm
6-K
EX-99.5
oqvs cl6cdtmyt
6 Nov 19
Notice of Annual General and Special Meeting of Shareholders
12:00am
6-K
EX-99.1
71980ot8435fi88dzu
24 Sep 19
Current report (foreign)
1:49pm
6-K
EX-99.2
8d9iut1ved43c0xz9zi
20 Sep 19
51-102F3 Material Change Report
1:31pm
6-K
EX-99.3
yqg36sb r8k323999gw
11 Sep 19
51-102F3 Material Change Report
12:13pm
6-K
EX-99.2
n4r8db8o04qu
11 Sep 19
51-102F3 Material Change Report
12:13pm
6-K
EX-99.1
6z1uacc
10 Sep 19
RepliCel's Partner, YOFOTO (China) Health, Unveils its Inaugural Cell Therapy Manufacturing Facility in China
11:22am
6-K
EX-99.1
m4ouc988dcig
29 Aug 19
RepliCel Life Sciences Retains Dermatology Sales and Marketing Executive to Guide the Global Commercial Strategy for its Automated Dermal Injector
11:47am
6-K
EX-99.2
ex5uo nj3
23 Aug 19
Condensed Consolidated Interim Financial Statements
3:47pm
6-K
EX-99.2
txe2gkbffa
30 May 19
Condensed Consolidated Interim Financial Statements
4:20pm
6-K
EX-99.1
t08lp2dmcpg dyme5qx
16 Apr 19
RepliCel Secures Several New Patents for its Regenerative Medicine Technologies
10:59am
6-K
EX-99.1
ozhq6trazkib 72mxb
26 Mar 19
Current report (foreign)
1:45pm
6-K
EX-99.1
kh89kw1ingco6aglzr
19 Mar 19
RepliCel Reignites its First-in-Japan Strategy
12:11pm
6-K
EX-99.1
x3gis1
6 Mar 19
51-102F3 Material Change Report
4:53pm
6-K
EX-99.1
pa1jf57 pg0ixz4vvt
5 Mar 19
RepliCel CEO Provides 2019 Shareholder Update
10:41am
6-K
EX-99.1
zffdyi 7k34yf
23 Jan 19
51-102F3 Material Change Report
12:44pm
6-K
EX-99.2
jhpiufkx4
26 Nov 18
Current report (foreign)
4:20pm
6-K
EX-99.1
39grfi z20pyrcrc8fl
6 Nov 18
RepliCel Life Sciences Appoints Head of Clinical and Regulatory Affairs
11:03am